Incorporating Stepped Care Approach Into e-CBT for Depression
Launched by DR. NAZANIN ALAVI · Feb 5, 2021
Trial Information
Current as of October 31, 2025
Completed
Keywords
ClinConnect Summary
Participants Participants (n = 110; 55 e-CBT participants, 55 e-CBT + stepped care participants) aged 18-65 years will be recruited at Queen's University from outpatient psychiatry clinic at both Kingston Health Sciences Centre sites (Hotel Dieu Hospital and Kingston General Hospital) as well as Providence Care hospital, family doctors, physicians, clinicians, and self-referrals in Kingston, Ontario, Canada. Once informed consent is provided, participants will be evaluated by a psychiatrist on the research team through secure video appointment to make or confirm a diagnosis of Major Depress...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-65 years at the start of the study
- • Diagnosis of major depressive disorder according to DSM-5 criteria
- • Competence to consent and participate
- • Ability to speak and read English
- • Consistent and reliable access to the internet
- Exclusion Criteria:
- • Active psychosis
- • Acute mania
- • Severe alcohol or substance use disorder
- • Active suicidal or homicidal ideation
- • Currently receiving another form of psychotherapy
About Dr. Nazanin Alavi
Dr. Nazanin Alavi is a distinguished clinical trial sponsor with extensive expertise in advancing medical research and innovation. With a strong background in clinical medicine and a commitment to enhancing patient outcomes, Dr. Alavi leads trials that focus on developing cutting-edge therapies and interventions across various therapeutic areas. Her collaborative approach ensures rigorous adherence to ethical standards and regulatory compliance, while fostering partnerships with leading research institutions and healthcare professionals. Dr. Alavi's dedication to scientific excellence and patient-centered research positions her as a key contributor to the field of clinical trials, driving advancements that aim to improve health and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kingston, Ontario, Canada
Patients applied
Trial Officials
Nazanin Alavi, MD, FRCPC
Principal Investigator
Queen's University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials